The KCNJ2 Knockout KYSE-30 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population targeting the human KCNJ2 gene, which encodes the inward rectifier potassium channel Kir2.1. This loss-of-function model is generated in the KYSE-30 esophageal squamous cell carcinoma host background and is supplied as a heterogeneous pool of edited cells, enabling robust functional studies without clonal selection artifacts. The polyclonal format preserves population-level diversity while achieving target-gene disruption via CRISPR/Cas9, making it suitable for investigating gene function in a cancer-relevant context.
KYSE-30 is a well-characterized adherent cell line derived from a well-differentiated invasive esophageal squamous cell carcinoma of a 64-year-old Japanese male. It harbors a missense mutation in the TP53 tumor suppressor gene, a hallmark of many esophageal cancers, and is widely utilized as an in vitro model for studying tumor biology, metastasis, and drug response. The cell line retains features of squamous differentiation and exhibits robust growth in standard culture conditions, making it amenable to a broad range of cellular and molecular analyses.
KCNJ2 encodes Kir2.1, a strong inward rectifier potassium channel that conducts the IK1 current critical for stabilizing the resting membrane potential and regulating potassium homeostasis in excitable and non-excitable cells. Kir2.1 activity is modulated by upstream regulators including protein kinase A (PKA), phosphatidylinositol 4,5-bisphosphate (PIP2), G-protein coupled receptor signaling, and intracellular magnesium. The channel interacts with scaffold proteins such as DLG1 (SAP97), syntrophins, PSD-95, and caveolin-3, which influence its localization and function. Downstream, Kir2.1-mediated membrane potential changes impact NFAT signaling, the MAPK/ERK pathway, cell volume regulation, and apoptosis sensitivity, linking potassium flux to broader cellular processes.
Disruption of KCNJ2 in KYSE-30 esophageal cancer cells eliminates the IK1 current, leading to depolarization of the resting membrane potential and altered potassium-dependent signaling. This perturbation is expected to impair cell volume regulation and may affect proliferative and migratory capacities, as well as susceptibility to apoptotic stimuli. Given the emerging role of ion channels in cancer progression, this knockout model provides a tool to dissect the contribution of Kir2.1 to the electrophysiological phenotype of esophageal squamous cell carcinoma and its potential interactions with TP53-mutated background.
Researchers can apply this polyclonal KCNJ2 knockout population in a variety of assays to investigate the functional consequences of Kir2.1 loss. Patch-clamp electrophysiology and membrane potential-sensitive dyes allow direct measurement of altered ionic currents and membrane potential. Western blotting and RNA-seq can assess changes in protein expression and transcriptional profiles. Functional assays, including proliferation, migration/invasion, and apoptosis assays, help elucidate the role of Kir2.1 in cancer cell behavior. Additionally, the model is suitable for drug sensitivity studies and co-immunoprecipitation experiments to probe protein?Cprotein interactions. For personalized technical support or to discuss custom projects, please contact Ascent Research.
